Skip to main content
. 2023 Oct 31;271(2):642–657. doi: 10.1007/s00415-023-11943-4

Fig. 3.

Fig. 3

Mean (SD) changes from baseline in immunoglobulin (Ig) fractions in the primary treatment and post-treatment follow-up periods, by initial randomization group. Assessed TFP assessed treatment-free period, BL baseline, Ig immunoglobulin, LLN lower limit of normal.